Oluwole Charles OMOLASE, Olusegun ADEKANLE, Bukola Olateju OMOLASE

Drug compliance amongst hypertensives in a Nigerian community

AMAÇ: Bu çalışma, Nijerya, Ondo Eyaleti, Owo Federal Tıp Merkezi’ndeki hipertansifler arasında ilaç uyumu derecesini belirlemek için tasarlandı. Aynı zamanda ilaç alım sıklığının ve alınan ilaç sayısının uyuma etkisini belirledik. YÖNTEM: Bu çalışma Eylül 2007-Ocak 2008 arasında yapıldı. Çalışma gerçekleştirilmeden önce hastane etik komitesinden etik onay alındı. Basit randomize teknikle seçilen 100 katılımcı ile yarı yapılandırılmış bir veri toplama formuyla görüşüldü. Aydınlatılmış onam her bir katılımcıdan alındı. Toplanan bilgiler katılımcıların biyolojik veriler, kendi beyan ettikleri ilaç uyumu, ilaç alım sıklığı ve kullanılan ilaç sayısıydı. Çalışma gereçleri ile toplanan veriler SPSS 12.0.1 yazılımı ile işlendi ve analiz edildi. Çapraz tablolar ve ki kare testleri yapıldı. İstatistiksel anlamlılık p

Nijerya toplumunda hipertansifler arasında ilaç uyumu

AIM : This study was designed to determine the degree of drug compliance amongst hypertensives at Federal Medical Centre Owo, Ondo State, Nigeria. We also determined the effect of frequency of dosing and number of drugs on compliance. METHODOLOGY : This study was conducted between September,2007 and January, 2008. Ethical clearance was obtained from the Ethical committee of the hospital prior to carrying out this study. Informed consent was obtained from each of the respondents. One hundred respondents were interviewed with the aid of semi structured questionnaire. Information obtained included their bio data, self reported drug compliance, frequency of dosing and the number of drugs used. The data obtained with the study instrument was collated and analyzed with SPSS 12.0.1 statistical soft ware version. Cross tabulation and chi square test was done. Statistical significance was P < 0.05. RESULTS :Most respondents (78%) had good drug compliance while the remaining had poor compliance. Majority of the respondents(65%) were on two drugs. Most respondents(80%) used their drugs twice daily. CONCLUSION : Majority of the respondents had good compliance. Even though frequency of dosing and the number of drugs affected drug compliance. The differences amongst the different groups were not statistically significant. Efforts at educating patients should be sustained and improved upon. There is need to make qualitative health care affordable and accessible to the populace.

PDF

___

1 Elzubier AG, Hussain AA ,Suleiman IA, Hamid ZA. Drug compliance among anti hypertensive patients in Kassala Eastern Sudan. Eastern Mediterranean Health Journal 2000; 6(1): 100-105.
2 Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee. Arch Intern Med 1993; 153: 154-87.
3 Muna WFT. Cardiovascular disorders in Africa. World Health Stat Q. 1993; 46(2): 125-133.
4 Whelton IK. Epidemiology of hypertension. Lancet. 1994; 344: 101-116.
5 Kabir M, IIiyasu Z, Abubakar IS, Jubril M. Compliance to medication among hypertensive patients in Murtala Mohammed Specialist Hospital Kano, Nigeria. Journal of Community Medicine and Primary HealthCare. 2004; 16(1): 16-20.
6 Hutchinson JC. Hypertension detection and compliance: Permanent Site Hypertension Evaluation. A new method of increasing patient compliance. Angiology. 1997; 30(8): 568-576.
7 Kaplan NM. Cardiovascular risk reduction: the role of anti hypertensive treatment. Am J Med 1991; 90: 19-20.
8 Haynes RB, Sackett DL, Gibson ES, et all. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976; 1(7972): 1265-1268.
9 Colhonn HM, Dung W, Poutter NR. Blood pressure screening, management and control in England: Results from the Health Survey for England 1994. J Hypertens. 1998; 16: 747-752.
10 Chalmers J, MacMahon S, Mancia G, et all. WHO/ISH Hypertension guidelines committee 1999 World Health Organization International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999; 17: 151-185.
11 Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in Hypertension: Facts and concepts. J Hypertens. 1985 ; 3(1): 3-9.
12 Wuerzner K, Hassler C, Burnier M. Difficult blood pressure control watch out for non-compliance. Nephrol Dial Transplant. 2003; 18: 1969-1973.
13 Joint National Committee on Prevention, Detection, Evaluation and Treatment of High blood pressure and the National High Blood Pressure Education Program Coordination Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation And Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 2413-2446.
14 Garfield FN, Caro JJ. Compliance and hypertension. Current Hypertension Reports. 1999; 1: 502-506.
15 Akpa MR, Agomuoh DI, Odia OJ. Drug compliance among hypertensives patients in Port Harcourt, Nigeria. Niger J Med. 2005; 14(1):55-57.
16 Buabeng KO, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Phamaceut. 2004; 7(3): 350-352.